Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.40 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.40 |
| ▸ | SCN1A known ✓ | P35498 | 1/20 | 0.39 |
| ▸ | SCN2A known ✓ | Q99250 | 1/20 | 0.39 |
| ▸ | SCN3A known ✓ | Q9NY46 | 1/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | BID | P55957 | 3/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octane SCHEMBL11401295 | 0.90 | CA1 (0.47) | CA1CA2CA9HTR6KDM4E | |
| SCHEMBL45790 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 | |
| SCHEMBL6743013 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 | |
| SCHEMBL378838 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 | |
| SCHEMBL99281 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 | |
| SCHEMBL18139200 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 | |
| SCHEMBL3073661 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 | |
| SCHEMBL339920 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 | |
| SCHEMBL18139086 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 | |
| SCHEMBL4144831 | 0.89 | LIPG (0.53) | LIPGKCNH2BIDMCL1BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2421510-B1 | PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE | ICEUTICA PTY LTD (AU) | 2019-07-31 | — | — | EP | claimed |
| US-20230356232-A1 | PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE | ICEUTICA PTY LTD. (AU) | 2023-11-09 | — | — | US | disclosed |
| EP-2421530-B1 | FORMULATION OF METAXALONE | ICEUTICA PTY LTD (AU) | 2019-08-21 | — | — | EP | disclosed |
| EP-2421510-B1 | PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE | ICEUTICA PTY LTD (AU) | 2019-07-31 | — | — | EP | disclosed |
| US-10172828-B2 | Formulation of indomethacin | ICEUTICA PTY LTD. (AU) | 2019-01-08 | — | — | US | disclosed |
| EP-3024440-B1 | FORMULATION OF METAXALONE | ICEUTICA INC (US) | 2018-11-28 | — | — | EP | disclosed |
| EP-3338766-A1 | PRODUCTION OF ENCAPSULATED NANOPARTICLES AT HIGH VOLUME FRACTIONS | Iceutica Pty Ltd. (AU) | 2018-06-27 | — | — | EP | disclosed |
| US-20180117008-A1 | Novel Formulation of Indomethacin | ICEUTICA PTY LTD. (AU) | 2018-05-03 | — | — | US | disclosed |
| EP-3290030-A1 | DICLOFENAC FORMULATION | Iceutica Pty Ltd. (AU) | 2018-03-07 | — | — | EP | disclosed |
| EP-2421509-B1 | PRODUCTION OF ENCAPSULATED NANOPARTICLES AT HIGH VOLUME FRACTIONS | ICEUTICA PTY LTD (AU) | 2017-11-22 | — | — | EP | disclosed |
| EP-3151835-A1 | A NOVEL FORMULATION OF MELOXICAM | Iceutica Pty Ltd. (AU) | 2017-04-12 | — | — | EP | disclosed |
| US-20170049788-A1 | Abiraterone Steroid Formulation | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2017-02-23 | — | — | US | disclosed |
| WO-2015191595-A1 | A NOVEL FORMULATION OF MELOXICAM | ICEUTICA PTY LTD. (AU) | 2015-12-17 | — | — | WO | disclosed |
| US-20150313857-A1 | Novel Formulation of Naproxen | ICEUTICA INC. | 2015-11-05 | — | — | US | disclosed |
| US-20150150805-A1 | NOVEL FORMULATION OF DICLOFENAC | ICEUTICA PTY LTD. | 2015-06-04 | — | — | US | disclosed |
| US-20150087709-A1 | Novel Formulation of Naproxen | ICEUTICA PTY LTD. | 2015-03-26 | — | — | US | disclosed |
| EP-2421540-A1 | A NOVEL FORMULATION OF MELOXICAM | Iceutica Pty Ltd. (AU) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010121325-A1 | A NOVEL FORMULATION OF MELOXICAM | ICEUTICA PTY LTD (AU) | 2010-10-28 | — | — | WO | disclosed |